Monitor 3 150 mg/75 mg/275 mg Tablet
Prescription Required
Introduction of Monitor 3 Tablet
Monitor 3 150 mg/75 mg/275 mg Tablet is a combination medicine used in the treatment of tuberculosis. It prevents the growth of the microorganisms that cause the infection.
Monitor 3 150 mg/75 mg/275 mg Tablet is a combination of rifampicin, isoniazid, and ethambutol.
Monitor 3 150 mg/75 mg/275 mg Tablet is a combination of rifampicin, isoniazid, and ethambutol.
Uses of Monitor 3 Tablet
Benefits of Monitor 3 Tablet
In Treatment of Tuberculosis (TB)
Tuberculosis is an infectious disease that mainly affects the lungs but can affect other parts of the body as well. Monitor 3 150 mg/75 mg/275 mg Tablet helps treat tuberculosis by stopping the growth of bacteria causing infection. Your symptoms might improve after using Monitor 3 150 mg/75 mg/275 mg Tablet. However, make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Side effects of Monitor 3 Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Monitor 3
- Nausea
- Vomiting
- Rash
- Fever
- Dark colored urine
- Sweating
- Increased sputum production
- Salivation
- Watery eyes
- Increased liver enzymes
- Jaundice
- Visual impairment
- Increased uric acid level in blood
- Gout
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Monitor 3 Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Monitor 3 150 mg/75 mg/275 mg Tablet is to be taken empty stomach.
Avoid Monitor 3 150 mg/75 mg/275 mg Tablet with tyramine-rich food such as cheese, smoked fish, meats and some types of beer.
Avoid Monitor 3 150 mg/75 mg/275 mg Tablet with tyramine-rich food such as cheese, smoked fish, meats and some types of beer.
Safety advice
Alcohol
UNSAFE
Consuming alcohol while taking Monitor 3 150 mg/75 mg/275 mg Tablet may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Pregnancy
CONSULT YOUR DOCTOR
Monitor 3 150 mg/75 mg/275 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Monitor 3 150 mg/75 mg/275 mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Driving
UNSAFE
Monitor 3 150 mg/75 mg/275 mg Tablet may cause side effects which could affect your ability to drive.
Monitor 3 150 mg/75 mg/275 mg Tablet occasionally causes sight problems and tingling or numbness in hand or feet. After taking this medicine you should not drive until you know how it affects you.
Monitor 3 150 mg/75 mg/275 mg Tablet occasionally causes sight problems and tingling or numbness in hand or feet. After taking this medicine you should not drive until you know how it affects you.
Kidney
CAUTION
Monitor 3 150 mg/75 mg/275 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Monitor 3 150 mg/75 mg/275 mg Tablet may be needed. Please consult your doctor.
Kidney function tests are advisable before the start of this medicine.
Kidney function tests are advisable before the start of this medicine.
Liver
CAUTION
Monitor 3 150 mg/75 mg/275 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Monitor 3 150 mg/75 mg/275 mg Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Monitor 3 150 mg/75 mg/275 mg Tablet
₹2.83/Tablet
Akurit-3 Tablet
Lupin Ltd
₹5.7/tablet
101% costlier
Exact 3 Tablet
Marc Laboratories Pvt Ltd
₹19.66/tablet
595% costlier
Mycurit 3 Tablet
Cadila Pharmaceuticals Ltd
₹3.95/tablet
40% costlier
Rimthree Fdc 150 mg/75 mg/275 mg Tablet
Novartis India Ltd
₹4.15/tablet
47% costlier
Quick tips
Monitor 3 Tablet
- It is best to take the medicine on an empty stomach one hour before or two hours after meals.
- Finish the prescribed course of medicine, even if you start to feel better. Stopping it early may make the infection harder to treat.
- It can make birth control pills less effective so ask the doctor about using a birth control method which does not affect your hormone levels (such as a condom, diaphragm, spermicide).
- It can cause temporary discoloration of your teeth, sweat, urine, saliva, and tears (red, orange, or brown color). This side effect is usually not harmful.
Fact Box
Habit Forming
No
Therapeutic Class
ANTI INFECTIVES
Patient concerns
Patient concerns
FAQs
Monitor 3 Tablet
Q. Which is the best time to take Monitor 3 150 mg/75 mg/275 mg Tablet?
Take Monitor 3 150 mg/75 mg/275 mg Tablet exactly as directed by your doctor. It is best to take the medicine on an empty stomach one hour before or two hours after meals.
Q. Can the use of Monitor 3 150 mg/75 mg/275 mg Tablet make birth control pills ineffective?
Yes, Monitor 3 150 mg/75 mg/275 mg Tablet can make birth control pills less effective. Ask the doctor about using a birth control method which does not affect your hormone levels (such as a condom, diaphragm, spermicide).
Q. Is tuberculosis a curable disease?
Yes, tuberculosis (TB) is a curable disease and can be cured with 6–9 months of treatment. Drug-resistant forms of TB are also curable, but more difficult to treat. Treatment for drug-resistant TB can last up to 2 years and require medications that can cause serious side effects.
Q. What are the instructions for the storage and disposal of Monitor 3 150 mg/75 mg/275 mg Tablet?
Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Q. Can the use of Monitor 3 150 mg/75 mg/275 mg Tablet cause discoloration of the urine?
Yes, Monitor 3 150 mg/75 mg/275 mg Tablet contains rifampicin which can cause temporary discoloration of your teeth, sweat, urine, saliva, and tears (red, orange, or brown color). This side effect is usually not harmful. However, discoloration of urine can be a sign of liver damage. Call your doctor if you have discoloration of urine with stomach pain, loss of appetite, and jaundice (yellowing of your skin or eyes).
Q. Can I discontinue Monitor 3 150 mg/75 mg/275 mg Tablet if I feel well?
No, do not discontinue Monitor 3 150 mg/75 mg/275 mg Tablet. Take the proper course of the drug that has been prescribed to you even if you begin to feel better. If you stop taking Monitor 3 150 mg/75 mg/275 mg Tablet, your infection may become worse and difficult to treat. It may even result in drug-resistant TB i.e. drugs you were taking may no longer work for Tuberculosis.
Q. Can Monitor 3 150 mg/75 mg/275 mg Tablet cause visual impairment?
Monitor 3 150 mg/75 mg/275 mg Tablet contains Ethambutol, which may cause visual impairment. Inform the doctor immediately if you notice any changes in your eyesight.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chemotherapy of Tuberculosis, Mycobacterium Avium Complex Disease, and Leprosy. In: Hilal-Dandan R, Brunton LL. Goodman and Gilman's Manual of Pharmacology and Therapeutics. 2nd ed. New York, New York: The McGraw-Hill Companies, Inc.; 2014. [Accessed 10 Apr. 2019] (online) Available from:
- Isoniazid. Nottingham, Nottinghamshire: Boots Contract Manufacturing; 2015. [Accessed 10 Apr. 2019] (online) Available from:
- Ethambutol. Ontario, Canada: Patheon Inc.; 2007. [Accessed 10 Apr. 2019] (online) Available from:
Marketer details
Name: Shreya Life Sciences Pvt Ltd
Address: SHREYA HOUSE, 301/A, Pereira Hill Road, Andheri East, Mumbai - 400 099, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
NOT FOR SALE
We do not facilitate sale of this product at present